Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from a patient.

“She said, ‘You know, you’ve been slipping a little bit, maybe you should get a test ... The last drug to be approved by the FDA for Alzheimer’s was in 2003 — and that was just ...

SHE’S THANKFUL HER FAMILY PUSHED HER TO GET ... Alzheimer's patients in nursing homes down. Anti-amyloid treatments target plaque in the brain. The FDA approved the first version of the drug ...

Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease ... drugs, but potentially life-threatening. It could also face a strong challenge if Eisai and Biogen get approval ...

FDA approval means Medicare covers both drugs ... get a referral before receiving care from UW Medicine. Now that donanemab is going out to patients, more questions about the future of Alzheimer ...

An FDA advisory committee has delivered a strong endorsement to Eli Lilly’s Alzheimer’s disease therapy donanemab, voting unanimously that the safety and efficacy of the amyloid-busting drug ...

On the neurodegenerative side, Etiome is working in Alzheimer’s disease, an area where ... The US Food and Drug Administration (FDA) has approved tau-based diagnostics and recently fast-tracked ...